Search Filters

Search Results

Found 6 results

510(k) Data Aggregation

    K Number
    K251406
    Device Name
    BriefCase-Triage
    Date Cleared
    2025-05-30

    (24 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    BriefCase-Triage

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    BriefCase-Triage is a radiological computer aided triage and notification software indicated for use in the analysis of CT chest, abdomen, or chest/abdomen exams with contrast (CTA and CT with contrast) in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspected positive findings of Aortic Dissection (AD) pathology.

    BriefCase-Triage uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings on a standalone desktop application in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

    The results of BriefCase-Triage are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/ prioritization.

    Device Description

    Briefcase-Triage is a radiological computer-assisted triage and notification software device. The software is based on an algorithm programmed component and is intended to run on a linux-based server in a cloud environment.

    The Briefcase-Triage receives filtered DICOM Images, and processes them chronologically by running the algorithms on each series to detect suspected cases. Following the AI processing, the output of the algorithm analysis is transferred to an image review software (desktop application). When a suspected case is detected, the user receives a pop-up notification and is presented with a compressed, low-quality, grayscale image that is captioned "not for diagnostic use, for prioritization only" which is displayed as a preview function. This preview is meant for informational purposes only, does not contain any marking of the findings, and is not intended for primary diagnosis beyond notification.

    Presenting the users with worklist prioritization facilitates efficient triage by prompting the user to assess the relevant original images in the PACS. Thus, the suspect case receives attention earlier than would have been the case in the standard of care practice alone.

    AI/ML Overview

    Here's a detailed breakdown of the acceptance criteria and study findings for BriefCase-Triage, based on the provided FDA 510(k) clearance letter:


    1. Table of Acceptance Criteria and Reported Device Performance

    ParameterAcceptance CriteriaReported Device Performance
    Primary EndpointsA lower bound 95% Confidence Interval (CI) of 80% for Sensitivity and Specificity at the default operating point.Default Operating Point:
    • Sensitivity: 92.7% (95% CI: 88.2%, 95.8%). The lower bound (88.2%) is > 80%.
    • Specificity: 92.8% (95% CI: 89.2%, 95.4%). The lower bound (89.2%) is > 80%.

    Additional Operating Points (AOPs) meeting criteria:

    • AOP1: Sensitivity 95.6% (95% CI: 91.8%-98.0%), Specificity 88.2% (95% CI: 84.0%-91.6%)
    • AOP2: Sensitivity 94.1% (95% CI: 90.0%-96.9%), Specificity 89.8% (95% CI: 85.8%-93.0%)
    • AOP3: Sensitivity 89.3% (95% CI: 84.2%-93.2%), Specificity 94.7% (95% CI: 91.6%-97.0%)
    • AOP4: Sensitivity 86.3% (95% CI: 80.9%-90.7%), Specificity 97.7% (95% CI: 95.3%-99.1%) |
      | Secondary Endpoints (Comparability with Predicate) | Time-to-notification metric for the Briefcase-Triage software should demonstrate comparability with the predicate device. | Briefcase-Triage (Subject Device): Mean time-to-notification = 10.7 seconds (95% CI: 10.5-10.9)
      Predicate AD: Mean time-to-notification = 38.0 seconds (95% CI: 35.5-40.4)

    The subject device's time-to-notification is faster than the predicate, demonstrating comparability and improvement in time savings. |

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: 509 cases.
    • Data Provenance:
      • Country of origin: 5 US-based clinical sites.
      • Retrospective or Prospective: Retrospective.
      • Data Sequestration: Cases collected for the pivotal dataset were "all distinct in time or center from the cases used to train the algorithm," and "Test pivotal study data was sequestered from algorithm development activities."

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    • Number of Experts: Three (3) senior board-certified radiologists.
    • Qualifications: "Senior board-certified radiologists." (Specific years of experience are not provided.)

    4. Adjudication Method for the Test Set

    • The text states "the ground truth, as determined by three senior board-certified radiologists." This implies a consensus-based adjudication, likely 3-0 or 2-1 (majority vote), but the exact method (e.g., 2+1, 3+1) is not explicitly detailed.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • Was it done? No.
    • The study primarily focused on the standalone performance of the AI algorithm compared to ground truth and a secondary comparison of time-to-notification with a predicate device. It did not evaluate human reader performance with and without AI assistance.

    6. Standalone Performance Study

    • Was it done? Yes.
    • The study evaluated the algorithm's performance (sensitivity, specificity, PPV, NPV, PLR, NLR) in identifying AD pathology without human intervention as a primary and secondary endpoint. The device's output is "flagging and communication of suspected positive findings" and "notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification," confirming a standalone function.

    7. Type of Ground Truth Used

    • Ground Truth: Expert Consensus, specifically "as determined by three senior board-certified radiologists."

    8. Sample Size for the Training Set

    • The document states, "The algorithm was trained during software development on images of the pathology." However, it does not specify the sample size for the training set. It only mentions that the pivotal test data was "distinct in time or center" from the training data.

    9. How the Ground Truth for the Training Set Was Established

    • "As is customary in the field of machine learning, deep learning algorithm development consisted of training on labeled ("tagged") images. In that process, each image in the training dataset was tagged based on the presence of the critical finding."
    • While it indicates images were "labeled ("tagged")" based on the "presence of the critical finding," it does not explicitly state who established this ground truth for the training set (e.g., experts, pathology, etc.). It's implied that medical professionals were involved in the labeling process, but no specific number or qualification is provided for the training set.
    Ask a Question

    Ask a specific question about this device

    K Number
    K250248
    Device Name
    BriefCase-Triage
    Date Cleared
    2025-02-14

    (18 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    BriefCase-Triage

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    BriefCase-Triage is a radiological computer aided triage and notification software indicated for use in the analysis of contrast-enhanced images that include the lungs in adults or transitional adolescents age 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of suspect cases of incidental Pulmonary Embolism (iPE) pathologies.

    BriefCase-Triage uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for suspect cases. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

    The results of BriefCase-Triage are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

    Device Description

    Briefcase-Triage is a radiological computer-assisted triage and notification software device. The software is based on an algorithm programmed component and is intended to run on a linux-based server in a cloud environment.

    The Briefcase-Triage receives filtered DICOM Images, and processes them chronologically by running the algorithms on each series to detect suspected cases. Following the AI processing, the output of the algorithm analysis is transferred to an image review software (desktop application). When a suspected case is detected, the user receives a pop-up notification and is presented with a compressed, low-quality, grayscale image that is captioned "not for diagnostic use, for prioritization only" which is displayed as a preview function. This preview is meant for informational purposes only, does not contain any marking of the findings, and is not intended for primary diagnosis beyond notification.

    Presenting the users with worklist prioritization facilitates efficient triage by prompting the user to assess the relevant original images in the PACS. Thus, the suspect case receives attention earlier than would have been the case in the standard of care practice alone.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study details for the BriefCase-Triage device, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    MetricAcceptance Criteria (Performance Goal)Reported Device Performance (Default Operating Point)95% Confidence Interval
    Sensitivity≥ 80%91.7%[87.5%, 94.9%]
    Specificity≥ 80%91.4%[87.3%, 94.6%]
    NPVNot specified99.8%[99.6%, 99.8%]
    PPVNot specified22.2%[16.1%, 29.9%]
    PLRNot specified10.7[7.2, 16.0]
    NLRNot specified0.09[0.06, 0.14]
    Time-to-NotificationComparability to predicate (282.63s)40.2 seconds[36.9, 43.5] (for subject device)

    Note on Additional Operating Points (AOPs): The document also describes four additional operating points (AOPs 1-4) designed to maximize specificity while maintaining a lower bound 95% CI of 80% for sensitivity. These AOPs achieved similar performance metrics, further demonstrating the device's flexibility.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: 498 cases
    • Data Provenance: Retrospective, blinded, multicenter study. Cases were collected from 6 US-based clinical sites. The test data was distinct in time or center from the cases used for algorithm training and was sequestered from algorithm development activities.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    • Number of Experts: Three (3)
    • Qualifications of Experts: Senior board-certified radiologists.

    4. Adjudication Method for the Test Set

    The specific adjudication method (e.g., 2+1, 3+1) is not explicitly stated in the provided text. It only mentions that the ground truth was "determined by three senior board-certified radiologists."

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

    A Multi-Reader Multi-Case (MRMC) comparative effectiveness study comparing AI assistance versus without AI assistance for human readers was not described for this device. The study primarily evaluated the standalone performance of the AI algorithm and its time-to-notification compared to the predicate device, not the improvement in human reader performance with AI assistance.

    6. If a Standalone (Algorithm Only Without Human-in-the-loop Performance) was done

    Yes, a standalone performance study was done. The "Pivotal Study Summary" sections describe the device's sensitivity, specificity, and other metrics based on its algorithm's performance in identifying iPE cases compared to the ground truth established by radiologists. The device is intended to provide notifications and not for diagnostic use, suggesting its performance is evaluated in its autonomous triage function.

    7. The Type of Ground Truth Used

    The ground truth used was expert consensus, specifically "determined by three senior board-certified radiologists."

    8. The Sample Size for the Training Set

    The sample size for the training set is not explicitly stated in the provided text. It only mentions that the algorithm was "trained during software development on images of the pathology."

    9. How the Ground Truth for the Training Set Was Established

    The ground truth for the training set was established through manual labeling ("tagging") by experts. The text states: "deep learning algorithm development consisted of training on manually labeled ("tagged") images. In that process, critical findings were tagged in all CTs in the training data set."

    Ask a Question

    Ask a specific question about this device

    K Number
    K243548
    Device Name
    BriefCase-Triage
    Date Cleared
    2024-12-11

    (26 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    BriefCase-Triage

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    BriefCase-Triage is a radiological computer aided triage and notification software indicated for use in the analysis of CT images with or without contrast that include the ribs, in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspect cases of three or more acute Rib fracture (RibFx) pathologies.

    BriefCase-Triage uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected RibFx findings. Notifications include compressed preview images that are meant for informational purposes only, and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

    The results of BriefCase-Triage are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

    Device Description

    BriefCase-Triage is a radiological computer-assisted triage and notification software device. The software is based on an algorithm programmed component and is intended to run on a linuxbased server in a cloud environment.

    The BriefCase-Triage receives filtered DICOM Images, and processes them chronologically by running the algorithms on each series to detect suspected cases. Following the Al processing, the output of the algorithm analysis is transferred to an image review software (desktop application). When a suspected case is detected, the user receives a pop-up notification and is presented with a compressed, low-quality, grayscale image that is captioned "not for diagnostic use, for prioritization only" which is displayed as a preview function. This preview is meant for informational purposes only, does not contain any marking of the findings, and is not intended for primary diagnosis beyond notification.

    Presenting the users with worklist prioritization facilitates efficient triage by prompting the user to assess the relevant original images in the PACS. Thus, the suspect case receives attention earlier than would have been the case in the standard of care practice alone.

    AI/ML Overview

    Acceptance Criteria and Device Performance for BriefCase-Triage

    1. Table of Acceptance Criteria and Reported Device Performance

    MetricAcceptance Criteria (Performance Goal)Reported Device Performance
    AUC> 0.9597.2% (95% Cl: 95.5%-99.0%)
    Sensitivity> 80%95.2% (95% Cl: 89.1%-98.4%)
    Specificity> 80%95.1% (95% Cl: 91.2%-97.6%)
    Time-to-notification (Mean)Comparability with predicate (70.1 seconds)41.4 seconds (95% Cl: 40.4-42.5)

    Note: The acceptance criteria for sensitivity and specificity are extrapolated from the statement "As the AUC exceeded 0.95 and sensitivity and specificity both exceeded 80%, the study's primary endpoints were met."

    2. Sample Size and Data Provenance for Test Set

    • Sample Size for Test Set: 308 cases
    • Data Provenance: Retrospective, multicenter study from 5 US-based clinical sites. The cases collected for the pivotal dataset were distinct in time or center from the cases used to train the algorithm.

    3. Number and Qualifications of Experts for Ground Truth

    • Number of Experts: Three senior board-certified radiologists.
    • Qualifications: Senior board-certified radiologists. (Specific years of experience are not provided in the document).

    4. Adjudication Method for Test Set

    The adjudication method is not explicitly stated. The document mentions "ground truth, as determined by three senior board-certified radiologists," but does not detail how disagreements among these radiologists were resolved (e.g., 2+1, 3+1, or simple consensus).

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No MRMC comparative effectiveness study was done to assess the effect of AI assistance on human readers' performance. The study focused on the standalone performance of the AI algorithm and its time-to-notification compared to a predicate device.

    6. Standalone Performance Study

    Yes, a standalone performance study was done. The "Pivotal Study Summary" section explicitly details the evaluation of the software's performance (AUC, sensitivity, specificity, PPV, NPV, PLR, NLR) in identifying RibFx without human intervention, comparing it to the established ground truth.

    7. Type of Ground Truth Used

    The ground truth used was expert consensus, determined by three senior board-certified radiologists.

    8. Sample Size for Training Set

    The sample size for the training set is not explicitly provided in the document. The document states, "The algorithm was trained during software development on images of the pathology. As is customary in the field of machine learning, deep learning algorithm development consisted of training on labeled ("tagged") images." It also mentions, "The cases collected for the pivotal dataset were all distinct in time or center from the cases used to train the algorithm, as was used for the most recent clearance (K230020)."

    9. How Ground Truth for Training Set Was Established

    The ground truth for the training set was established by labeling ("tagging") images based on the presence of the critical finding (three or more acute Rib fractures). This process is described as "each image in the training dataset was tagged based on the presence of the critical finding." The document does not specify who performed this tagging or the exact methodology for establishing the ground truth for the training set (e.g., expert consensus, pathology).

    Ask a Question

    Ask a specific question about this device

    K Number
    K242837
    Device Name
    BriefCase-Triage
    Date Cleared
    2024-10-18

    (29 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    BriefCase-Triage

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    BriefCase-Triage is a radiological computer aided triage and notification software indicated for use in the analysis of CT scans that include the cervical spine, in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communication of linear lucencies in the cervical spine bone in patterns compatible with fractures.

    BriefCase-Triage uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

    The results of BriefCase-Triage are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

    Device Description

    BriefCase-Triage is a radiological computer-assisted triage and notification software device.

    The software is based on an algorithm programmed component and is intended to run on a linuxbased server in a cloud environment.

    The BriefCase-Triage receives filtered DICOM Images, and processes them chronologically by running the algorithms on each series to detect suspected cases. Following the Al processing, the output of the algorithm analysis is transferred to an image review software (desktop application). When a suspected case is detected, the user receives a pop-up notification and is presented with a compressed, low-quality, grayscale image that is captioned "not for diagnostic use, for prioritization only" which is displayed as a preview function. This preview is meant for informational purposes only, does not contain any marking of the findings, and is not intended for primary diagnosis beyond notification.

    Presenting the users with worklist prioritization facilitates efficient triage by prompting the user to assess the relevant original images in the PACS. Thus, the suspect case receives attention earlier than would have been the case in the standard of care practice alone.

    The algorithm was trained during software development on images of the pathology. As is customary in the field of machine learning algorithm development consisted of training on manually labeled ("tagged") images. In that process, critical findings were tagged in all CTs in the training data set.

    AI/ML Overview

    The Aidoc BriefCase-Triage device, intended for triaging cervical spine CT scans for fractures, underwent a retrospective, blinded, multicenter study to evaluate its performance.

    Here's a breakdown of the acceptance criteria and study details:

    1. A table of acceptance criteria and the reported device performance

    Acceptance CriteriaReported Device Performance
    Sensitivity (performance goal ≥ 80%)92.1% (95% CI: 87.5%, 95.4%)
    Specificity (performance goal ≥ 80%)92.6% (95% CI: 89.0%, 95.4%)
    Time-to-Notification (comparable to predicate)15.1 seconds (95% CI: 14.1-16.2)

    2. Sample size used for the test set and the data provenance

    • Sample Size: 487 cases
    • Data Provenance: Retrospective, multicenter study from 6 US-based clinical sites. The cases collected for the pivotal dataset were all distinct in time or center from the cases used to train the algorithm.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Number of Experts: Three
    • Qualifications: Senior board-certified radiologists

    4. Adjudication method for the test set

    The document does not explicitly state the adjudication method (e.g., 2+1, 3+1). However, it implies that the ground truth was "as determined by three senior board-certified radiologists," suggesting a consensus-based approach among these experts.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    There is no MRMC comparative effectiveness study presented in this document that evaluates human readers' improvement with AI assistance versus without AI assistance. The study focuses on the standalone performance of the AI device and its time-to-notification compared to a predicate device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Yes, a standalone algorithm-only performance study was done. The primary endpoints (sensitivity and specificity) and secondary endpoints (time-to-notification, PPV, NPV, PLR, NLR) directly measure the performance of the BriefCase-Triage software itself.

    7. The type of ground truth used

    The ground truth was established by expert consensus (determined by three senior board-certified radiologists).

    8. The sample size for the training set

    The document states, "The algorithm was trained during software development on images of the pathology." However, it does not specify the sample size for the training set. It only mentions that the test pivotal study data was sequestered from algorithm development activities.

    9. How the ground truth for the training set was established

    The ground truth for the training set was established by manually labeled ("tagged") images. The document states, "critical findings were tagged in all CTs in the training data set." This implies expert annotation of the training data.

    Ask a Question

    Ask a specific question about this device

    K Number
    K241727
    Device Name
    BriefCase-Triage
    Date Cleared
    2024-07-12

    (28 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    BriefCase-Triage

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Briefcase-Triage is a radiological computer- aided triage and notification software indicated for use in the analysis of CTPA images, in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of Pulmonary Embolism (PE) pathologies.

    Briefcase-Triage uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected PE findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

    The results of Briefcase-Triage are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

    Device Description

    Briefcase-Triage is a radiological computer-assisted triage and notification software device. The software is based on an algorithm programmed component and is intended to run on a linux-based server in a cloud environment.

    The Briefcase-Triage receives filtered DICOM Images, and processes them chronologically by running the algorithms on each series to detect suspected cases. Following the Al processing, the output of the algorithm analysis is transferred to an image review software (desktop application). When a suspected case is detected, the user receives a pop-up notification and is presented with a compressed, low-quality, grayscale image that is captioned "not for diagnostic use, for prioritization only" which is displayed as a preview function. This preview is meant for informational purposes only, does not contain any marking of the findings, and is not intended for primary diagnosis beyond notification.

    Presenting the users with worklist prioritization facilitates efficient triage by prompting the user to assess the relevant original images in the PACS. Thus, the suspect case receives attention earlier than would have been the case in the standard of care practice alone.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study details for the Aidoc BriefCase-Triage device, based on the provided document:

    1. Table of Acceptance Criteria and Reported Device Performance

    Device Name: BriefCase-Triage (for Pulmonary Embolism - PE)

    Acceptance CriteriaPerformance GoalReported Device Performance (Default Operating Point)
    Sensitivity≥ 80%94.39% (95% CI: 90.41%, 97.07%)
    Specificity≥ 80%94.39% (95% CI: 91.04%, 96.67%)
    Time-to-notification (compared to predicate)Comparable benefit in time savingMean 26.42 seconds (95% CI: 25.3-27.54) vs Predicate's 78.0 seconds (95% CI: 73.6-82.3)

    Additional Operating Points (AOPs) Performance:

    Operating PointSensitivity (95% CI)Specificity (95% CI)
    AOP199.53% (97.42%-99.99%)86.67% (82.16%-90.39%)
    AOP297.66% (94.63%-99.24%)91.93% (88.14%-94.82%)
    AOP391.59% (87.03%-94.94%)96.49% (93.64%-98.3%)
    AOP485.98% (80.6%-90.34%)98.25% (95.95%-99.43%)

    Other reported secondary endpoints for the default operating point:

    • NPV: 98.96% (95% CI: 98.21%- 99.4%)
    • PPV: 74.79% (95% CI: 64.80%- 82.7%)
    • PLR: 16.81 (95% CI: 10.43- 27.09)
    • NLR: 0.059 (95% CI: 0.034- 0.103)

    2. Sample Size and Data Provenance for the Test Set

    • Sample Size: 499 cases
    • Data Provenance: Retrospective, multicenter study from 6 US-based clinical sites. The cases were distinct in time or center from the cases used to train the algorithm.

    3. Number of Experts and Qualifications for Ground Truth

    • Number of Experts: Three (3)
    • Qualifications: Senior board-certified radiologists.

    4. Adjudication Method

    • The document states "the ground truth as determined by three senior board-certified radiologists." It does not explicitly state the adjudication method (e.g., 2+1, consensus, majority vote). However, "determined by" implies that their collective judgment established the ground truth for each case.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • No, a multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly described. The study focuses on the standalone performance of the AI algorithm against a ground truth established by experts, and a comparison of its notification time with a predicate device. It does not evaluate human reader performance with and without AI assistance.

    6. Standalone Performance Study

    • Yes, a standalone study (algorithm only without human-in-the-loop performance) was conducted. The primary endpoints (sensitivity and specificity) evaluated the device's ability to identify PE cases independently.

    7. Type of Ground Truth Used

    • Expert Consensus: The ground truth was "determined by three senior board-certified radiologists"

    8. Sample Size for the Training Set

    • The document states that the algorithm was "trained during software development on images of the pathology" and that the subject device was trained on a "larger data set" compared to the predicate. However, it does not specify the exact sample size of the training set.

    9. How Ground Truth for the Training Set was Established

    • "critical findings were tagged in all CTs in the training data set." This implies manual labeling (annotation) of findings by experts on the training images. While not explicitly stated, it is common practice that these tags are done by medical professionals.
    Ask a Question

    Ask a specific question about this device

    K Number
    K232751
    Device Name
    BriefCase-Triage
    Date Cleared
    2023-10-30

    (52 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    BriefCase-Triage

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    BriefCase-Triage is a radiological computer-aided triaqe and notification software indicated for use in the analysis of CTPA images in adults or transitional adolescents aged 18 and older. The device is intended to assist hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive cases of Central Pulmonary Embolism (Central PE).

    BriefCase-Triage uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings in parallel to the ongoing standard of care image interpretation. The user is presented with notifications for cases with suspected Central PE findings. Notifications include compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification. The device does not alter the original medical image and is not intended to be used as a diagnostic device.

    The results of BriefCase-Triage are intended to be used in conjunction with other patient information and based on their professional judgment, to assist with triage/prioritization of medical images. Notified clinicians are responsible for viewing full images per the standard of care.

    Device Description

    BriefCase-Triage is a radiological computer-assisted triage and notification software device. The software is based on an algorithm programmed component and is intended to run on a linux-based server in a cloud environment.

    The BriefCase-Triage receives filtered DICOM images, and processes them chronologically by running the algorithms on each series to detect suspected cases. Following the Al processing, the output of the algorithm analysis is transferred to an image review software (desktop application). When a suspected case is detected, the user receives a pop-up notification and is presented with a compressed, low-quality, grayscale image that is captioned "not for diagnostic use, for prioritization only" which is displayed as a preview function. This preview is meant for informational purposes only, does not contain any marking of the findings, and is not intended for primary diagnosis beyond notification.

    Presenting the users with worklist prioritization facilitates efficient triage by prompting the user to assess the relevant original images in the PACS. Thus, the suspect case receives attention earlier than would have been the case in the standard of care practice alone.

    The algorithm was trained during software development on images of the pathology. As is customary in the field of machine learning, deep learning algorithm development consisted of training on manually labeled ("tagged") images. In that process, critical findings were tagged in all CTs in the training data set.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study details for the Aidoc BriefCase-Triage device, based on the provided FDA 510(k) summary:

    1. Table of Acceptance Criteria and Reported Device Performance

    The FDA 510(k) summary explicitly states the primary performance goals and the achieved results.

    Acceptance Criteria (Performance Goal)Reported Device Performance
    Sensitivity ≥ 80%89.2% (95% CI: 82.5%, 93.9%)
    Specificity ≥ 80%94.5% (95% CI: 90.3%, 97.2%)

    Note on Secondary Endpoints: While time-to-notification, PPV, NPV, PLR, and NLR were assessed as secondary endpoints, the document does not state explicit acceptance criteria for them, but rather presents them as comparative data or additional performance metrics.

    2. Sample Size and Data Provenance

    • Test Set Sample Size: 328 cases from unique patients.
    • Data Provenance: Retrospective, multi-center study with data from 6 US-based clinical sites. The cases collected for the pivotal dataset were distinct in time or center from the cases used to train the algorithm.

    3. Number of Experts and Qualifications for Ground Truth

    • Number of Experts: 3 senior board-certified radiologists.
    • Qualifications of Experts: Senior board-certified radiologists. (No specific years of experience are detailed, but "senior" implies extensive experience).

    4. Adjudication Method for the Test Set

    • Adjudication Method: Majority voting among the three senior board-certified radiologists was used to establish the ground truth.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • Was an MRMC study done? No, a comparative effectiveness study involving human readers with and without AI assistance (MRMC) was not performed as the primary evaluation for this device. The study compared the algorithm's performance to ground truth, and the device is intended for workflow triage/notification, not as a diagnostic tool replacing human interpretation. The time-to-notification comparison was done between the device and a predicate device (PETN), not human readers.

    6. Standalone (Algorithm Only) Performance Study

    • Was a standalone study done? Yes. The pivotal study directly evaluated the BriefCase-Triage software's performance (sensitivity and specificity) in identifying Central PE by comparing its output against the established ground truth. This is a standalone performance evaluation.

    7. Type of Ground Truth Used

    • Type of Ground Truth: Expert consensus (majority voting by three senior board-certified radiologists).

    8. Sample Size for the Training Set

    • The document states that the algorithm was "trained during software development on images of the pathology." However, the exact sample size for the training set is not specified in the provided text.

    9. How Ground Truth for the Training Set Was Established

    • Method: "Critical findings were tagged in all CTs in the training data set." This implies manual labeling/tagging of findings by experts. The specific number or qualifications of these "tagging" experts are not detailed, but it's consistent with a machine learning development process.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1